Results 151 to 160 of about 2,806,410 (297)

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

Molecular Oncology, EarlyView.
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, Joe Ibrahim, Dieter Peeters, Suresh Krishan Yogeswaran, Wen Wen, Paul Van Schil, Jeroen M. H. Hendriks, Jo Raskin, Jan van Meerbeeck, Guy Van Camp, Ken Op de Beeck   +12 more
wiley   +1 more source

Interpretation of charge transfer measurements of brush discharges

, 2011
Kanchan Chowdhury, Ulrich von Pidoll, Dieter Moeckel, Tim Langer, Michael Beyer   +4 more
openalex   +1 more source

Ceremonial exchange and art on Moce Island (Fiji): a functional interpretation of a tapa design [PDF]

, 1980
Simon Kooijman
openalex   +1 more source

Perspectives in educating molecular pathologists on liquid biopsy: Toward integrative, equitable, and decentralized precision oncology

Molecular Oncology, EarlyView.
Liquid biopsy enables minimally invasive, real‐time molecular profiling through analysis of circulating biomarkers in biological fluids. This Perspective highlights the importance of training pathologists through integrative educational programs, such as the European Masters in Molecular Pathology, to ensure effective and equitable implementation of ...
Marius Ilié, Umberto Malapelle, Catherine Alix‐Panabières, Claus Lindbjerg Andersen, Sandra Chlebowski, Vivien Lake, Caroline Lacoux, Virginie Lespinet‐Fabre, Olivier Bordone, Simon Heeke, Christophe Bontoux, Ellen Heitzer, Klaus Pantel, Paul Hofman   +13 more
wiley   +1 more source

Factors associated with junior doctor plain trauma X-ray interpretation accuracy and strategies for improvement: a scoping review. [PDF]

BMC Med Imaging
Acquah G, Anyitey-Kokor IC, Donkor A, Wiafe YA, Ohene-Botwe B, Neep MJ, Alhassan I, Brennan PC.   +7 more
europepmc   +1 more source

Data Driven - Interpreter Guided Geobody Interpretation [PDF]

, 2013
Nicholas McArdle, J. Lowell
openalex   +1 more source

Transcriptional network analysis of PTEN‐protein‐deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication

Molecular Oncology, EarlyView.
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice, Jose I. Lopez, Aitziber Ugalde‐Olano, Maite Zufiaurre, Ianire Astobiza, Natalia Martin‐Martin, Laura Bozal‐Basterra, Saioa Garcia‐Longarte, Amaia Zabala‐Letona, Sofia Rey, Aida Santos‐Martin, Miguel Unda, Ana Loizaga‐Iriarte, Mariona Graupera, Paolo Nuciforo, Arkaitz Carracedo, Isabel Mendizabal   +16 more
wiley   +1 more source

Corrigendum to "Pro-dopaminergic pharmacological interventions for anhedonia in depression: a living systematic review and network meta-analysis of human and animal studies", EBioMedicine. 2025 Nov;121:105967. doi: 10.1016/j.ebiom.2025.105967. [PDF]

EBioMedicine
Ostinelli EG, Salanti G, Macleod M, Chiocchia V, Smith KA, Stringaris A, Downs J, Robinson ESJ, Malhi GS, Dwyer DM, Chevance A, Correll C, Tonia T, Wheeler E, Furukawa TA, Pizzagalli DA, Browning M, Potts J, Cipriani A.   +18 more
europepmc   +1 more source

Recognition, interpretation and teaching of sign lan-guage in the official languages of Ecuador

, 2018
Miguel Á. Redondo, Blanca Naula, Diego Reina, Cristian Arellano   +3 more
openalex   +2 more sources

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source